Breaking News Instant updates and real-time market news.

PTE

PolarityTE

$5.05

-0.14 (-2.70%)

15:09
08/20/19
08/20
15:09
08/20/19
15:09

PolarityTE's patent approval increases probability of patent protection, says Cantor Fitzgerald

Cantor Fitzgerald analyst Elemer Piros notes that PolarityTE was granted a patent by the Canadian Intellectual Property Office related to methods for development and use of minimally polarized function cell micro-aggregate units. The analyst believes that having received the first patent approval, and maintaining a record with no abandoned or lapsed patents, increases the probability of receiving patent protection in other markets. Piros feels confident that direct competition is not a threat at this time given the trade secrets in place for PolarityTE's unique platform. Additionally, the analyst highlights that since creating the Office of the Chief Executive in June, the company has accomplished a number of significant milestones, and he expects more important updates to occur in the second half of 2019. Piros reiterates an Overweight rating and $50 price target on the shares.

  • 20

    Aug

  • 21

    Aug

  • 09

    Sep

PTE PolarityTE
$5.05

-0.14 (-2.70%)

05/10/19
PIPR
05/10/19
NO CHANGE
Target $26
PIPR
Overweight
Piper cuts 2019 sales estimate for PolarityTE's SkinTE by 75% to $5M
Piper Jaffray analyst Tyler Van Buren says that while adoption of PolarityTE's SkinTE is improving with the number of patients treated up 47% quarter-over-quarter in Q1, sales of $297,000 were below expectations due to an increase in the proportion of lower cost chronic wounds. Following the results, the analyst reset his near-term launch expectations and decreased his 2019 annual SkinTE sales estimate to $5M from $20M. However, Van Buren's long-term sales estimates are still largely intact at over $300M. As such, he keeps an Overweight rating on PolarityTE shares.
07/08/19
HCWC
07/08/19
INITIATION
Target $8
HCWC
Buy
PolarityTE initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started PolarityTE with a Buy rating and $8 price target. The company's SkinTE has the potential to revolutionize the $40B wound care market, Ramakanth tells investors in a research note. Further, PolarityTE has made several leadership changes in the last three months that could "well change the face of the investment prospects," adds the analyst. He believes the company's technology platform could expand to many products.
08/08/19
PIPR
08/08/19
NO CHANGE
Target $26
PIPR
Overweight
Piper says PolarityTE sales need to start ramping to stay confident in forecasts
Piper Jaffray analyst Tyler Van Buren said he is encouraged by several of the changes that PolarityTE's new management has made, but he needs to see sales start ramping in the next couple of quarters to have continued confidence in his long-term SkinTE sales projections of over $300M. Paid cases need to increase "significantly more" than 12% quarter-over-quarter and "both new and repeat users need to be going in the right direction, every quarter," said Van Buren. While awaiting the hoped for execution, he keeps an Overweight rating and $26 price target on PolarityTE shares.
08/09/19
OPCO
08/09/19
NO CHANGE
Target $14
OPCO
Outperform
PolarityTE price target lowered to $14 from $24 at Oppenheimer
Oppenheimer analyst Kevin DeGeeter lowered his price target for PolarityTE to $14 from $24 and maintained an Outperform rating following the company's second quarter results. In a research note to investors, DeGeeter says he believes new management was effective in providing better transparency on metrics of commercial uptake of SkinTE, rationale for a more targeted sales effort in acute and chronic wounds and a timeline for re-engaging the burn market.

TODAY'S FREE FLY STORIES

CEO

Cnooc

$162.07

10.57 (6.98%)

12:05
09/16/19
09/16
12:05
09/16/19
12:05
Upgrade
Cnooc rating change  »

Cnooc upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$41.87

0.06 (0.14%)

12:05
09/16/19
09/16
12:05
09/16/19
12:05
Conference/Events
Boston Scientific participates in a conference call with SVB Leerink »

Conference call with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 13

    Nov

NEWR

New Relic

$53.86

-4.48 (-7.68%)

12:01
09/16/19
09/16
12:01
09/16/19
12:01
Recommendations
New Relic analyst commentary  »

New Relic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$16.91

-1.94 (-10.29%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -10.2% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCO

Scor ADR

$13.52

-3.825 (-22.06%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Scor ADR falls -21.8% »

Scor ADR is down -21.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$4.37

-2.11 (-32.56%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Britannia Bulk falls -32.8% »

Britannia Bulk is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$14.50

2.68 (22.67%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
California Resources rises 22.6% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$10.27

2.74 (36.39%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
Whiting Petroleum rises 36.5% »

Whiting Petroleum is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.31

0.16 (0.18%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Options
Puts lead calls 15:1 in High Yield Bond ETF on vertical spread buyer »

Puts lead calls 15:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEMG

SemGroup

$16.82

6.54 (63.62%)

12:00
09/16/19
09/16
12:00
09/16/19
12:00
Hot Stocks
SemGroup rises 63.6% »

SemGroup is up 63.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
09/16/19
09/16
12:00
09/16/19
12:00
General news
Treasury's $87 B 3- and 6-month bill auction results were generally below average »

Treasury's $87 B 3-…

VLGEA

Village Super Market

$26.70

0.05 (0.19%)

11:53
09/16/19
09/16
11:53
09/16/19
11:53
Hot Stocks
Village Super Market board of directors authorizes $5M share repurchase program »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$52.62

0.875 (1.69%)

11:51
09/16/19
09/16
11:51
09/16/19
11:51
Upgrade
Total rating change  »

Total upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

OCN

Ocwen

$2.00

0.01 (0.50%)

11:50
09/16/19
09/16
11:50
09/16/19
11:50
Options
April call buyer in $2 stock Ocwen Financial »

April call buyer in $2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$18.42

8.37 (83.28%)

11:47
09/16/19
09/16
11:47
09/16/19
11:47
Downgrade
Alder Biopharmaceuticals rating change  »

Alder Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Feb

MET

MetLife

$47.56

-0.8 (-1.65%)

11:40
09/16/19
09/16
11:40
09/16/19
11:40
Options
Large call seller appears to average up on short calls in MetLife »

Large call seller appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

EQNR

Equinor

$20.16

0.72 (3.70%)

11:39
09/16/19
09/16
11:39
09/16/19
11:39
Upgrade
Equinor rating change  »

Equinor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

UBER

Uber

$34.57

1.33 (4.00%)

, LYFT

Lyft

$48.63

2.53 (5.49%)

11:37
09/16/19
09/16
11:37
09/16/19
11:37
On The Fly
Upgrades of Uber and Lyft, downgrade of HP among today's top analyst actions »

Check out today's top…

UBER

Uber

$34.57

1.33 (4.00%)

LYFT

Lyft

$48.63

2.53 (5.49%)

HPQ

HP Inc.

$18.82

-0.26 (-1.36%)

DKS

Dick's Sporting

$38.92

-0.1 (-0.26%)

ACB

Aurora Cannabis

$5.60

-0.34 (-5.72%)

WLL

Whiting Petroleum

$10.54

3.01 (39.97%)

JAG

Jagged Peak Energy

$8.43

0.96 (12.85%)

CDEV

Centennial Resource Development

$5.67

1.26 (28.57%)

SM

SM Energy

$11.64

2 (20.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 26

    Sep

  • 08

    Oct

  • 09

    Oct

  • 13

    Nov

11:36
09/16/19
09/16
11:36
09/16/19
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:36
09/16/19
09/16
11:36
09/16/19
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

AEGN

Aegion

$21.25

0.06 (0.28%)

11:32
09/16/19
09/16
11:32
09/16/19
11:32
Hot Stocks
Aegion's Insituform awarded $6.9M wastewater pipeline rehabilitation contract »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$41.57

-0.34 (-0.81%)

11:30
09/16/19
09/16
11:30
09/16/19
11:30
Options
Big winner takes gains and rolls strike up in China Largecap ETF »

Big winner takes gains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKR

Baker Hughes

$0.00

(0.00%)

, BHGE

Baker Hughes

$23.04

0.315 (1.39%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Hot Stocks
GE ceases to hold 50% of Baker Hughes voting power after secondary »

Baker Hughes, a GE…

BKR

Baker Hughes

$0.00

(0.00%)

BHGE

Baker Hughes

$23.04

0.315 (1.39%)

GE

General Electric

$9.38

0.04 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

LYFT

Lyft

$48.54

2.44 (5.29%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Options
Lyft call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$14.38

-0.78 (-5.15%)

11:25
09/16/19
09/16
11:25
09/16/19
11:25
Conference/Events
Atara Biotherapeutics participates in a conference call with JPMorgan »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.